Business Context and Reporting Period
Company: HAPC, Inc. (formerly Healthcare Acquisition Partners Corp.), a Delaware corporation in the development stage.
Reporting Period: Quarterly period ended March 31, 2006.
Business Model: A "blank check" company (Special Purpose Acquisition Company) formed to acquire one or more operating businesses primarily in the healthcare sector. As of the reporting date, the company had no operating history and had not yet completed its Initial Public Offering (IPO).
Key Financial Metrics
| Metric | Three Months Ended March 31, 2006 | Period from Inception (Aug 15, 2005) to March 31, 2006 |
|---|---|---|
| Revenue | $0 | $0 |
| Net Loss | $(2,198,721) | $(2,223,504) |
| Loss Per Share (Basic) | $(1.26) | $(0.73) |
| Cash and Cash Equivalents | $9,197 | $9,197 |
| Total Assets | $616,177 | $616,177 |
| Total Liabilities | $618,658 | $618,658 |
| Stockholders' Deficit | $(2,481) | $(2,481) |
| Notes Payable | $85,000 | $85,000 |
| Accrued Expenses | $533,558 | $533,558 |
Note: The net loss for the quarter was primarily driven by non-cash stock-based compensation expenses ($2,196,616) related to the issuance of shares to management.
Material Changes and Recent Developments
- Post-Period IPO: Although the balance sheet reflects a pre-IPO status, the company consummated its IPO on April 18, 2006, selling 16,666,667 units at $6.00 per unit. On May 18, 2006, an additional 208,584 units were sold via partial exercise of the overallotment option.
- Cash Position: Cash on hand at March 31, 2006, was minimal ($9,197). Following the IPO, the company received gross proceeds of approximately $101.25 million. Approximately $96.2 million was deposited into a Trust Account, with the remainder available for working capital.
- Debt Repayment: The $85,000 in notes payable outstanding at March 31, 2006, were repaid in full in May 2006 using IPO proceeds.
- Stock-Based Compensation: A significant portion of the accumulated deficit ($2.22 million) is attributed to the amortization of stock-based compensation for shares issued to management, which are subject to forfeiture if employment terminates prior to specific dates.
Outlook, Risks, and Contingencies
- Business Combination Deadline: The company must consummate a business combination within 18 months of the IPO (or 24 months if extended). Failure to do so will result in mandatory liquidation.
- Liquidation Risk: If liquidation occurs, public stockholders may receive less than the $6.00 IPO price per share due to expenses and potential claims against the trust account. Warrants will expire worthless.
- Trust Account: $95 million (plus interest) from the IPO is held in a Trust Account invested in U.S. government securities. This amount includes a contingent underwriting fee of approximately $5.4 million payable only upon a successful business combination.
- Management Conflicts: Officers and directors have other business interests and may have conflicts regarding the allocation of time or the presentation of business opportunities. They hold shares that will not participate in liquidation distributions, creating a potential conflict of interest in selecting a target.
- Regulatory Risks: As a healthcare-focused SPAC, the company faces risks related to industry regulation, including FDA requirements, Medicare/Medicaid reimbursement changes, and liability exposure.
Investor Verification Checklist
- Verify the status of the Trust Account and the exact amount available for distribution in a liquidation scenario.
- Confirm the timeline for the mandatory liquidation date (18 or 24 months post-IPO).
- Review the vesting and forfeiture schedules for management shares to understand potential future dilution or expense recognition.
- Assess the contingent underwriting fees and their impact on the net assets available for a business combination.
- Monitor the company's progress in identifying a target business within the healthcare sector.